Compound information
- Natural Products
- ZC2730064
- Molecular Formula
- C29H30N2O5
- Molecular Weight
- 486.21547206 g/mol
- Structure
-
- IUPAC Name
- benzyl (2S)-2-[[(1S)-1-benzyl-2-benzyloxy-2-oxo-ethyl]carbamoyl]pyrrolidine-1-carboxylate
- InChI
- InChI=1S/C29H30N2O5/c32-27(26-17-10-18-31(26)29(34)36-21-24-15-8-3-9-16-24)30-25(19-22-11-4-1-5-12-22)28(33)35-20-23-13-6-2-7-14-23/h1-9,11-16,25-26H,10,17-21H2,(H,30,32)/t25-,26-/m0/s1
- InChI Key
- UNLFUNMHNNKFCF-UIOOFZCWSA-N
- SMILES
- O=C(OCc1ccccc1)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1C(=O)OCc1ccccc1
- Source
- ZINC000025693608
Warheads
- Carbamate
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 36 | Ring Count | 4 |
Heteroatom Count | 7 | Rotatable Bond Count | 9 |
Hydrogen Bond Acceptor Count | 5 | Hydrogen Bond Donor Count | 1 |
Topological Polar Surface Area | 84.94 Å2 | LogP | 4.934 |
LogS | -6.779 | LogD | 4.888 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.039 | Pgp substrate | 0.03 |
HIA | 0.964 | F20 % | 0.974 |
F30 % | 0.01 | Caco-2 | -4.583 |
MDCK | -4.579 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.0 | PPB | 97.919 |
VD | 1.129 | Fu | 2.069 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 0.172 | CYP1A2 substrate | 0.675 |
CYP2A6 substrate | 0.386 | CYP2B6 substrate | 0.596 |
CYP2C19 inhibitor | 0.868 | CYP2C19 substrate | 0.924 |
CYP2C8 substrate | 0.865 | CYP2C9 inhibitor | 0.719 |
CYP2C9 substrate | 1.0 | CYP2D6 inhibitor | 0.085 |
CYP2D6 substrate | 0.893 | CYP2E1 substrate | 0.219 |
CYP3A4 inhibitor | 0.639 | CYP3A4 substrate | 0.999 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.486 | CL | 5.511 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.41 | Hepatotoxicity | 0.841 |
Mutagenicity | 0.023 | Rat Oral Acute Toxicity | 0.722 |
FDAMDD | 0.918 | Skin Sensitization | 0.01 |
Carcinogenicity | 0.018 | Eye Corrosion | 0.005 |
Eye Irritation | 0.009 | Respiratory Toxicity | 0.053 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | 1.005 | IGC50 | 4.893 |
LC50FM | 2.107 | LC50DM | 4.696 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.351 | NR-AR-LBD | 0.17 |
NR-AhR | 0.025 | NR-Aromatase | 0.205 |
NR-ER | 0.433 | NR-ER-LBD | 0.529 |
NR-PPAR-gamma | 0.303 | SR-ARE | 0.396 |
SR-ATAD5 | 0.509 | SR-HSE | 0.508 |
SR-MMP | 0.837 | SR-p53 | 0.067 |
Similar covalent inhibitors
Similar covalent drugs
No similar covalent drugs found for this compound.